Ftse Mib
37.100,33
1,42%
DAX
21.902,42
1,63%
S&P 500
6.083,57
0,36%
NASDAQ
19.791,99
0,51%
Bitcoin
96.362,22
-0,28%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Panacea Acquisition Corp (NUVB) Panacea Acquisition Corp (NUVB) Notizie

Panacea Acquisition Corp

NUVB
2,38
-0,07 (-2,86%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 23:01:32
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/2/202514:00BWNuvation Bio Announces Expanded Access Program in the U.S...
06/1/202522:05BWNuvation Bio to Present at the 43rd Annual J.P. Morgan..
06/1/202514:00BWNuvation Bio Receives Approval from China’s National Medical..
23/12/202414:00BWU.S. Food and Drug Administration Accepts for Priority..
20/12/202413:10PRNUSInnovent Receives Approval of DOVBLERON® (Taletrectinib..
26/11/202414:00BWNuvation Bio to Present at the 7th Annual Evercore ISI..
13/11/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202422:05BWNuvation Bio to Present at the Jefferies London Healthcare..
06/11/202422:43EDGAR2Form 8-K - Current report
06/11/202422:41EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202422:05BWNuvation Bio Reports Third Quarter 2024 Financial Results..
10/10/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/10/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/10/202422:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/10/202422:05BWNuvation Bio Appoints Industry Veteran Philippe Sauvage as..
14/9/202409:05BWPositive Pooled Data from Nuvation Bio’s TRUST-I and..
09/9/202414:00BWNuvation Bio to Present at the Cantor Global Healthcare..
05/9/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202422:35EDGAR2Form 8-K - Current report
16/8/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
15/8/202422:46EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/8/202422:02EDGAR2Form DEFR14A - Revised definitive proxy soliciting materials
05/8/202422:58EDGAR2Form S-3 - Registration statement under Securities Act of..
05/8/202414:44EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/8/202414:37EDGAR2Form 8-K - Current report
05/8/202414:00BWNuvation Bio Reports Second Quarter 2024 Financial Results..
30/7/202422:01EDGAR2Form DEF 14A - Other definitive proxy statements
23/7/202422:05BWNuvation Bio Announces Updates and Upcoming Presentations..
16/7/202415:03EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
01/6/202414:10BWNuvation Bio Announces Data from Pivotal Phase 2 TRUST-I..
29/5/202422:05BWNuvation Bio to Present at the Jefferies Global Healthcare..
24/5/202423:22EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
24/5/202422:40EDGAR2Form PRE 14A - Other preliminary proxy statements
14/5/202422:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202422:20EDGAR2Form 8-K - Current report
14/5/202422:05BWNuvation Bio Reports First Quarter 2024 Financial Results..
24/4/202416:01BWNuvation Bio to Present Updated Data on Taletrectinib, a..
10/4/202422:01BWNuvation Bio Completes Acquisition of AnHeart Therapeutics
28/3/202413:00BWNuvation Bio Announces Appointment of Colleen Sjogren as..
25/3/202412:00BWNuvation Bio to Acquire AnHeart Therapeutics in All-Stock..
14/3/202421:05BWNuvation Bio Doses First Patient in Phase 1/2 Study of..
04/3/202423:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/3/202423:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202422:48EDGAR2Form 8-K - Current report
29/2/202422:01BWNuvation Bio Reports Fourth Quarter and Full Year 2023..
Apertura: 2,46 Min: 2,38 Max: 2,46
Chiusura: 2,45

La tua Cronologia

NYSE
NUVB
Panacea Acquisition
AQSE
AAU.GB
Ariana
BIT
UB891Z
Unicredit Bank
BIT
S29775
Societe Generale Effekten
BIT
UC4KSA
Unicredit Bank
BIT
S32591
Societe Generale Effekten
BIT
F35096
Vontobel Financial Produ...
BIT
F36428
Vontobel Financial Produ...
BIT
S28296
Societe Generale Effekten
BIT
UB7RYF
Unicredit Bank
BIT
UC92TS
Unicredit Bank
BIT
I07328
INTESA SANPAOLO
BIT
QFVIG
Rreef Fondimmobiliari Sgr
BIT
1TMUS
T Mobile USA
BIT
FDRV
Fidelity Electric Vehicl...
BIT
WSPX
Wisdomtree S&p 500
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci